Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;70(2):84-91.
doi: 10.1111/pin.12881. Epub 2019 Dec 19.

Loss of nectin-3 expression as a marker of tumor aggressiveness in pancreatic neuroendocrine tumor

Kenichi Hirabayashi  1 , Takuma Tajiri  2 , Dustin E Bosch  3 , Masashi Morimachi  4 , Masashi Miyaoka  1 , Chie Inomoto  1 , Naoya Nakamura  1 , Matthew M Yeh  3   5
Affiliations

Loss of nectin-3 expression as a marker of tumor aggressiveness in pancreatic neuroendocrine tumor

Kenichi Hirabayashi et al. Pathol Int. 2020 Feb.

Abstract

Pancreatic neuroendocrine tumors (PanNETs) are rare, and prediction of aggressive characteristics, such as recurrence and metastasis and prognosis of PanNETs remain difficult. Nectins are cell adhesion molecules that regulate the formation of adherens and tight junctions. In this study, we investigated the clinicopathological significance of nectin-3 expression in patients with PanNETs. Immunohistochemical analysis of nectin-3 expression was performed on 78 cases of PanNET. Low nectin-3 expression in the membrane (positive ratio ≤25%) was observed in 62 cases (79.5%) and was significantly correlated with larger tumor size (>20 mm; P = 0.003), G2/G3 tumors (P = 0.025), higher Ki67 labeling index (≥3%; P = 0.009), lymphatic involvement (P = 0.047), advanced pT-factor (T2-T4; P = 0.003), lymph node metastasis (P = 0.006), advanced Union for International Cancer Control/American Joint Committee on Cancer-stage (Stage II-IV; P = 0.001), advanced ENETS stage (Stage IIa-IV; P = 0.001), nonfunctioning tumors (P = 0.002), and a shorter disease-free survival (P = 0.019). However, there was no significant correlation between nectin-3 expression in the membrane and/or cytoplasm and the clinicopathological parameters. The present results suggest that decreased nectin-3 expression in the membrane is associated with increased tumor aggressiveness of PanNETs. Clinically, immunohistochemical analysis of nectin-3 may help predict tumor aggressiveness for PanNETs.

Keywords: cell adhesion molecules; cell proliferation; nectin-3; neuroendocrine tumor; pancreas.

PubMed Disclaimer

References

REFERENCES

    1. Lloyd R, Osamura R, Klöppel G et al. WHO Classification of Tumours of Endocrine Organs, 4th edn. Lyon: IARC, 2017.
    1. Franko J, Feng W, Yip L, Genovese E, Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: Incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg 2010; 14: 541-48.
    1. Halfdanarson TR, Rabe K, Rubin J, Petersen GM. Pancreatic neuroendocrine tumors (PNETs): Incidence, prognosis and recent trend toward improved survival. Ann Oncol 2008; 19: 1727-33.
    1. Ali A, Serra S, Asa SL, Chetty R. The predictive value of CK19 and CD99 in pancreatic endocrine tumors. Am J Surg Pathol 2006; 30: 1588-94.
    1. Corbo V, Beghelli S, Bersani S et al. Pancreatic endocrine tumours: Mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries. Ann Oncol 2012; 23: 127-34.

LinkOut - more resources